BioSpace News Archive

Biotech Beach

Emmaus Life Sciences Announces Endari® To Be Added to the Florida Medicaid Preferred Drug List

Emmaus Life Sciences, Inc. announced that the Florida Medicaid Pharmaceutical & Therapeutics Committee has approved adding Endari the company’s prescription-grade L-glutamine oral powder for the treatment of sickle cell disease, to the Florida Medicaid Preferred Drug List, effective April 1, 2022.

March 29, 2022
·
3 min read
Drug Development

Albireo Completes Enrollment in Pivotal Phase 3 ASSERT Study of BylvayTM (odevixibat) in Alagille Syndrome

Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced the completion of patient enrollment in the ASSERT study, a Phase 3 pivotal trial of Bylvay (odevixibat) in patients with Alagille syndrome (ALGS).

March 29, 2022
·
11 min read
Biotech Beach

Medical Technologies Leader Cellmyx Announces U.S. Food and Drug Administration (FDA) 510(k) Clearance for intelliFat® BOD™ (Ref.# K210528)

Cellmyx, the authority on autologous adipose grafting and transfer, and a leader in medical technologies for orthopedic physicians, pain management and regenerative medicine, announces U.S. Food and Drug Administration (FDA) 510(k) clearance for intelliFat® BOD™ (Ref.# K210528).

March 29, 2022
·
3 min read
Pharm Country

Bayer to Highlight New Cardiovascular and Renal Data at ACC.22, Including Late-Breaking Presentations for KERENDIA® (finerenone) as Well as Oral Factor XIa Inhibitor (asundexian) Program

Bayer will present a range of new clinical data at the American College of Cardiology’s 71st Annual Scientific Session (ACC.22), being held April 2-4, 2022, in Washington, D.C.

March 29, 2022
·
12 min read
Prestige Biopharma Enters MOU with Vaxine for Supply of COVID-19 Vaccine and Co-development of COVID-19/Influenza Combo Vaccine

Prestige Biopharma Limited and Vaxine Pty Ltd announced that the two organizations have entered into a memorandum of understanding (MOU) to collaborate on the supply of Vaxine’s COVID-19 Vaccine, Covax-19® (also known as Spikogen®) and on the co-development of COVID-19/influenza combo vaccine.

March 29, 2022
·
4 min read
CellOrigin Closed a New Round of Investment to Jump-start its iPSC Immune Cell Therapy Products Toward Clinics

CellOrigin Inc, a biotech company focusing on iPSC-derived immune cell therapies, announced it secured a new round of investment of ~100 million RMB from Jifeng Ventures, Kunlun Capital, Yinxinggu Capital and Efung Capital.

March 29, 2022
·
2 min read
Pharm Country

Delcath Systems to Participate in the Lytham Partners Spring 2022 Investor Conference

Delcath Systems, Inc. announced that it will be participating in the Lytham Partners Spring 2022 Investor Conference, via presentation and panel discussion.

March 29, 2022
·
1 min read
Biotech Beach

Capricor Therapeutics to Participate in the Cantor Fitzgerald Rare Orphan Disease Summit

Capricor Therapeutics announced that Dr. Linda Marbán, CEO of Capricor, will participate in a panel discussion at the virtual Cantor Fitzgerald Rare Orphan Disease Summit on March 30, 2022.

March 29, 2022
·
3 min read
Pharm Country

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Two Premier Pain Clinics

Milestone Scientific Inc. today announced that it has commenced sales of the CompuFlo ® Epidural disposables at the Cypress Surgery Center in Santa Maria, California and the Galileo Surgery Center in San Luis Obispo.

March 29, 2022
·
2 min read
Biotech Bay

Biotechnology Leader Purissima Receives Three New U.S. Patents

Today, Purissima, Inc, a leading, next-generation biotechnology health and wellness company, announced the grant of three new U.S. Patents 11,193,151, 11,242,546 and 11,242,547, which further solidifies the brand’s work in the fast-growing bioengineering industry.

March 29, 2022
·
2 min read